Suppr超能文献

黄酮类化合物在肝纤维化中的潜力:全面综述。

The potential of flavonoids in hepatic fibrosis: A comprehensive review.

机构信息

Faculty of Chinese Medicine, Jiangsu College of Nursing, Huaian 223001, China.

Key Laboratory of Basic and Application Research of Beiyao (Heilongjiang University of Chinese Medicine), Ministry of Education, Heilongjiang University of Chinese Medicine, Harbin 150000, China.

出版信息

Phytomedicine. 2024 Oct;133:155932. doi: 10.1016/j.phymed.2024.155932. Epub 2024 Aug 8.

Abstract

BACKGROUND

Hepatic fibrosis is a pathophysiological process of extracellular matrix abnormal deposition induced by multiple pathogenic factors. Currently, there is still a lack of effective and non-toxic drugs for treating fibrosis in clinic. Flavonoids are polyphenolic compounds synthesized in plants and modern pharmacological studies confirmed flavonoids exhibit potent hepatoprotective effect.

PURPOSE

Summarize literature to elaborate the mechanism of HF and evaluate the potential of flavonoids in HF, aiming to provide a new perspective for future research.

METHODS

The literatures about hepatic fibrosis and flavonoids are collected via a series of scientific search engines including Google Scholar, Elsevier, PubMed, CNKI, WanFang, SciFinder and Web of Science database. The key words are "flavonoids", "hepatic fibrosis", "pharmacokinetic", "toxicity", "pathogenesis" "traditional Chinese medicine" and "mechanism" as well as combination application.

RESULTS

Phytochemical and pharmacological studies revealed that about 86 natural flavonoids extracted from Chinese herbal medicines possess significantly anti-fibrosis effect and the mechanisms maybe through anti-inflammatory, antioxidant, inhibiting hepatic stellate cells activation and clearing activated hepatic stellate cells.

CONCLUSIONS

This review summarizes the flavonoids which are effective in HF and the mechanisms in vivo and in vitro. However, fewer studies are focused on the pharmacokinetics of flavonoids in HF model and most studies are limited to preclinical studies, therefore there is no reliable data from clinical trials for the development of new drugs. Further in-depth research related it can be conducted to improve the bioavailability of flavonoids and serve the development of new drugs.

摘要

背景

肝纤维化是由多种致病因素引起的细胞外基质异常沉积的病理生理过程。目前,临床上仍缺乏有效、无毒的抗纤维化药物。类黄酮是植物合成的多酚类化合物,现代药理研究证实类黄酮具有很强的保肝作用。

目的

总结文献阐述肝纤维化的发病机制,评价类黄酮在肝纤维化中的应用潜力,为今后的研究提供新的思路。

方法

通过一系列科学搜索引擎,包括 Google Scholar、Elsevier、PubMed、CNKI、万方、SciFinder 和 Web of Science 数据库,收集有关肝纤维化和类黄酮的文献。关键词为“类黄酮”、“肝纤维化”、“药代动力学”、“毒性”、“发病机制”、“中药”和“机制”以及联合应用。

结果

植物化学和药理学研究表明,约 86 种从中草药中提取的天然类黄酮具有显著的抗纤维化作用,其作用机制可能通过抗炎、抗氧化、抑制肝星状细胞活化和清除活化的肝星状细胞。

结论

本综述总结了类黄酮在肝纤维化中的作用及体内、体外的作用机制。然而,关于类黄酮在肝纤维化模型中的药代动力学研究较少,且大多数研究仅限于临床前研究,因此,新药开发尚无可靠的临床试验数据。进一步深入研究相关内容可以提高类黄酮的生物利用度,为新药的开发服务。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验